Evanson Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Evanson Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 22, 2021	SELL	$28.04 - $50.26 $253,762 - $454,853	-9,050 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$27.21 - $41.0 $136,050 - $205,000	-5,000 Reduced 35.59%	9,050 $248,000
Q1 2020 Apr 24, 2020	SELL	$19.54 - $38.85 $17,976 - $35,742	-920 Reduced 6.15%	14,050 $421,000
Q4 2019 Jan 13, 2020	SELL	$17.95 - $29.41 $103,302 - $169,254	-5,755 Reduced 27.77%	14,970 $414,000
Q1 2018 Apr 05, 2018	BUY	$8.1 - $19.5 $54,067 - $130,162	6,675 Added 47.51%	20,725 $350,000
Q3 2017 Nov 14, 2017	BUY	$4.45 - $8.55 $62,522 - $120,127	14,050	14,050 $109,000

342

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $562M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Evanson Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Evanson Asset Management, LLC with notifications on news.